123 related articles for article (PubMed ID: 4604627)
1. Intra-arterially administered reserpine and saline in scleroderma.
Siegel RC; Fries JF
Arch Intern Med; 1974 Sep; 134(3):515-8. PubMed ID: 4604627
[No Abstract] [Full Text] [Related]
2. Intraarterial reserpine administration in Raynaud syndrome.
McFadyen IJ; Housley E; MacPherson AI
Arch Intern Med; 1973 Oct; 132(4):526-8. PubMed ID: 4742406
[No Abstract] [Full Text] [Related]
3. [Intra-arterial reserpine in Raynaud's disease and syndrome].
Arcas Meca R; Ono Okabe S; Barroso-Moguel R; Quijano Pitman F
Arch Inst Cardiol Mex; 1972; 42(2):260-8. PubMed ID: 5028993
[No Abstract] [Full Text] [Related]
4. Medical uses of intra-arterial injections of reserpine. Treatment of Raynaud syndrome and of some vascular insufficiencies of the lower extremities.
Tindall JP; Whalen RE; Burton EE
Arch Dermatol; 1974 Aug; 110(2):233-7. PubMed ID: 4604746
[No Abstract] [Full Text] [Related]
5. [Sympatholytic effect of intra-arterial reserpine in sclerodermia and Raynaud's disease].
Acevedo A; Palacios JM; López R; Palma F
Rev Med Chil; 1984 Jun; 112(6):553-8. PubMed ID: 6515168
[No Abstract] [Full Text] [Related]
6. [Raynaud syndrome].
Knorr M; Schmid A; steurer J; Vetter W
Schweiz Rundsch Med Prax; 1986 Jul; 75(29):893-6. PubMed ID: 3738337
[No Abstract] [Full Text] [Related]
7. [Treatment of raynaud's disease and phenomenon with intraarterial reserpine (author's transl)].
González Folch M; Saffie F
Rev Med Chil; 1976 Jan; 104(1):21-4. PubMed ID: 788084
[No Abstract] [Full Text] [Related]
8. Liquid crystal thermography: a measure of therapeutic response to reserpine given intra-arterially.
Chandler C
South Med J; 1976 May; 69(5):614-5. PubMed ID: 1273622
[TBL] [Abstract][Full Text] [Related]
9. Intra-arterial reserpine for Raynaud's syndrome. Systemic reactions without therapeutic benefit.
Surwit RS; Gilgor RS; Duvic M; Allen LM; Neal JA
Arch Dermatol; 1983 Sep; 119(9):733-5. PubMed ID: 6614959
[TBL] [Abstract][Full Text] [Related]
10. Effect of intra-arterial reserpine in patients suffering from Raynaud's phenomenon.
Acevedo A; Reginato AJ; Schnell AM
J Cardiovasc Surg (Torino); 1978; 19(1):77-84. PubMed ID: 627597
[TBL] [Abstract][Full Text] [Related]
11. Intra-arterial administration of reserpine. Its use in patients with Raynaud's disease or Raynaud's phenomenon.
Romeo SG; Whalen RE; Tindall JP
Arch Intern Med; 1970 May; 125(5):825-9. PubMed ID: 5444311
[No Abstract] [Full Text] [Related]
12. Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis.
Gore J; Silver R
Ann Rheum Dis; 2005 Sep; 64(9):1387. PubMed ID: 16100356
[No Abstract] [Full Text] [Related]
13. [Reserpine administration by retrograde intravenous route in patients with Raynaud's phenomenon].
Acevedo A; Arinoviche R; Palma A; Olea E; Guzmán G; Arriagada M; Grisanti M; Testar R
Rev Med Chil; 1982 Nov; 110(11):1063-5. PubMed ID: 7184095
[No Abstract] [Full Text] [Related]
14. Cutaneous microcirculation in systemic sclerosis and response to intra-arterial reserpine.
Nilsen KH; Jayson MI
Br Med J; 1980 Jun; 280(6229):1408-11. PubMed ID: 7427134
[TBL] [Abstract][Full Text] [Related]
15. Reserpine in Raynaud's disease and phenomenon. Short-term response to intra-arterial injection.
Willerson JT; Thompson RH; Hookman P; Herdt J; Decker JL
Ann Intern Med; 1970 Jan; 72(1):17-27. PubMed ID: 5410395
[No Abstract] [Full Text] [Related]
16. Ketanserin in the treatment of progressive systemic sclerosis.
Altomare GF; Pigatto PD; Polenghi MM
Angiology; 1988 Jul; 39(7 Pt 1):583-6. PubMed ID: 3408023
[TBL] [Abstract][Full Text] [Related]
17. Bosentan: new indication. Scleroderma and finger ulcers: no tangible efficacy.
Prescrire Int; 2008 Dec; 17(98):238. PubMed ID: 19422150
[TBL] [Abstract][Full Text] [Related]
18. Ischemic finger ulcer as a presenting symptom of systemic sclerosis.
Balbir-Gurman A; Markovits D; Nahir AM; Rozin A; Braun-Moscovici Y
Isr Med Assoc J; 2005 Aug; 7(8):531-2. PubMed ID: 16106783
[No Abstract] [Full Text] [Related]
19. [Prolonged intravenous and intra-arterial administration of large doses of Raubasine in peripheral arterial diseases].
Raso AM; Silvestrini P
Minerva Med; 1973 Mar; 64(19):961-9. PubMed ID: 4703313
[No Abstract] [Full Text] [Related]
20. Effect of reserpine in Raynaud's phenomenon.
Kontos HA; Wasserman AJ
Circulation; 1969 Feb; 39(2):259-66. PubMed ID: 5763842
[No Abstract] [Full Text] [Related]
[Next] [New Search]
